Use of Somatostatin Analogs in Patients With Neuroendocrine Tumors

Video

Wouter W. de Herder, MD, PhD, professor of Endocrine Oncology, Erasmus MC, discusses the use of somatostatin analogs in patients with neuroendocrine tumors, as well as significant clinical trials investigating these agents.

Related Videos
Related Content